Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China
· Delayed Price · Currency is CNY 17.30
+0.27 (1.59%)
Apr 29, 2026, 3:00 PM CST
SHA:688488 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | -19.53 | -141.2 | -76.07 | -124.09 | -29.99 | Upgrade
|
| Depreciation & Amortization | 55.11 | 53.17 | 45.1 | 37.85 | 30.21 | Upgrade
|
| Other Amortization | 5.62 | 3.53 | 2.65 | 3.51 | 2.44 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.08 | - | -0.07 | -0.03 | -1.58 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.17 | 29.39 | 23.8 | 0.31 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -17.48 | -17.73 | -14.16 | -14.14 | -8.09 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.37 | -3.34 | 3.72 | 8.87 | -2.49 | Upgrade
|
| Other Operating Activities | 59.93 | 54.72 | 11.77 | 36.21 | 10.89 | Upgrade
|
| Change in Accounts Receivable | -24.12 | 76.98 | -82.92 | -66.66 | 31.35 | Upgrade
|
| Change in Inventory | -21.53 | -44.28 | -52.4 | -74.62 | -36.7 | Upgrade
|
| Change in Accounts Payable | -26.22 | -14.34 | -8.84 | 118.87 | 3.87 | Upgrade
|
| Change in Other Net Operating Assets | 3.71 | -5.31 | -2.8 | - | - | Upgrade
|
| Operating Cash Flow | 17.63 | -37.5 | -166.22 | -92.55 | -12.37 | Upgrade
|
| Capital Expenditures | -47.93 | -44.56 | -71.2 | -140.3 | -94.78 | Upgrade
|
| Sale of Property, Plant & Equipment | 4.08 | 0.12 | 1.32 | 0.68 | 0.01 | Upgrade
|
| Cash Acquisitions | -5.04 | 16.35 | - | - | - | Upgrade
|
| Investment in Securities | 20.75 | 109 | 135.88 | -274.75 | 311.12 | Upgrade
|
| Other Investing Activities | 1.51 | 4.19 | 7.44 | 8.64 | 14.17 | Upgrade
|
| Investing Cash Flow | -26.63 | 85.1 | 73.44 | -405.72 | 230.53 | Upgrade
|
| Long-Term Debt Issued | 477.92 | 410.87 | 395.29 | 205 | - | Upgrade
|
| Total Debt Issued | 477.92 | 410.87 | 395.29 | 205 | - | Upgrade
|
| Long-Term Debt Repaid | -407.01 | -340.15 | -198.33 | -5.5 | -2.76 | Upgrade
|
| Total Debt Repaid | -407.01 | -340.15 | -198.33 | -5.5 | -2.76 | Upgrade
|
| Net Debt Issued (Repaid) | 70.91 | 70.72 | 196.96 | 199.5 | -2.76 | Upgrade
|
| Issuance of Common Stock | - | - | 5.48 | - | - | Upgrade
|
| Common Dividends Paid | -20.87 | -15.85 | -11.66 | -3.47 | -20.16 | Upgrade
|
| Financing Cash Flow | 50.04 | 54.86 | 190.78 | 196.03 | -22.92 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.1 | -0.01 | 0 | 0.47 | -0.15 | Upgrade
|
| Net Cash Flow | 40.94 | 102.46 | 98 | -301.77 | 195.08 | Upgrade
|
| Free Cash Flow | -30.3 | -82.06 | -237.43 | -232.85 | -107.15 | Upgrade
|
| Free Cash Flow Margin | -4.21% | -19.64% | -57.72% | -95.34% | -41.90% | Upgrade
|
| Free Cash Flow Per Share | -0.07 | -0.20 | -0.56 | -0.56 | -0.25 | Upgrade
|
| Cash Income Tax Paid | 100.19 | 22.87 | 22.29 | -6.67 | 11.66 | Upgrade
|
| Levered Free Cash Flow | -35.46 | -9.52 | -247.6 | -196.07 | -81.12 | Upgrade
|
| Unlevered Free Cash Flow | -25.69 | 0.08 | -240.24 | -193.62 | -80.97 | Upgrade
|
| Change in Working Capital | -66.46 | -16.04 | -162.97 | -41.05 | -13.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.